RxDoctor Payments Data

Kara Rood, MD

Maternal & Fetal Medicine · Columbus, OHNPI 1306170147

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $90,078 of the $118,548 with a category attached, or 76.0%. Organon accounts for 82.8% of it on its own, with 4 other manufacturers making up the rest. Among maternal & fetal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$118,548in general payments, 2019–2025

Across 133 payments — averaging $891.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$98K
  • Gilead$15K
  • Coopersurgical, Inc.$5K
  • Alydia Health$726
  • Indivior Inc.$15
$201,935in research payments, 2019–2025

Across 25 payments — averaging $8077.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cytyc Corporation$96K
  • Roche Diagnostics Corporation$89K
  • Alydia Health$16K
  • Hologic Inc$2K

What the payments were for

  • Consulting fees$19,89017%
  • Speaking & faculty fees$90,07876%
  • Travel & lodging$7,0936%
  • Food & beverage$1,4871%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon101$98,161
Gilead19$14,716
Coopersurgical, Inc.7$4,930
Alydia Health5$726
Indivior Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$118,548 in reported general payments places this provider in the 95th percentile of 77 maternal & fetal medicine providers in Ohio.

See all maternal & fetal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$1,578
Medicare patients
13
Services billed
36

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$332

Paid to pharmacies, not to this prescriber.

Other maternal & fetal medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →